As biomarker studies employ increasingly complex and expensive genomics and other correlative methods, it is increasingly important to rigorously design these studies and analyze the downstream ...
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results